Related Experiment Video
Updated: Jun 2, 2026

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis
Published on: October 18, 2024
Histone onco-modifications
J Füllgrabe1, E Kavanagh, B Joseph
1Department of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Post-translational modification of histones provides an important regulatory platform for processes such as gene expression, DNA replication and repair, chromosome condensation and segregation and apoptosis. Disruption of these processes has been linked to the multistep process of carcinogenesis. We review the aberrant covalent histone modifications observed in cancer, and discuss how these epigenetic changes, caused by alterations in histone-modifying enzymes, can contribute to the development of a variety of human cancers. As a conclusion, a new terminology 'histone onco-modifications' is proposed to describe post-translational modifications of histones, which have been linked to cancer. This new term would take into account the active contribution and importance of these histone modifications in the development and progression of cancer.
Insights
Aberrant histone modifications, epigenetic changes impacting gene regulation, are linked to cancer development. The study proposes "histone onco-modifications" to describe these cancer-associated histone changes.
Area of Science:
- Epigenetics and Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Post-translational modifications (PTMs) of histones regulate crucial cellular processes.
- Disruption of these PTMs is implicated in carcinogenesis.
- Aberrant histone modifications are observed in various human cancers.
Purpose of the Study:
- To review aberrant covalent histone modifications in cancer.
- To discuss the contribution of epigenetic changes in histone modification to cancer development.
- To propose new terminology for cancer-associated histone modifications.
Main Methods:
- Literature review of studies on histone modifications and cancer.
- Analysis of the role of histone-modifying enzymes in cancer epigenetics.
- Synthesis of findings to propose a new term.
Main Results:
- Histone PTMs are critical for gene expression, DNA repair, and chromosome dynamics.
- Alterations in histone-modifying enzymes lead to aberrant histone modifications.
- These epigenetic changes contribute to the development and progression of human cancers.
Conclusions:
- A new term, 'histone onco-modifications,' is proposed.
- This terminology highlights the active role of histone modifications in cancer.
- Understanding histone onco-modifications is crucial for cancer research and therapy.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Histone Variants at the Centromere
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

